Increased [

Digital SiPM PET/CT scanner NET Physiological uptake Uncinate pancreatic process [68Ga]Ga-DOTATATE [68Ga]Ga-DOTATOC [68Ga]Ga-SST PET/CT

Journal

EJNMMI reports
ISSN: 3005-074X
Titre abrégé: EJNMMI Rep
Pays: England
ID NLM: 9918752082606676

Informations de publication

Date de publication:
24 Jun 2024
Historique:
received: 06 03 2024
accepted: 10 04 2024
medline: 24 6 2024
pubmed: 24 6 2024
entrez: 23 6 2024
Statut: epublish

Résumé

A physiological increase in the uptake of [ We analyzed all consecutive NET patients from July 2018 to June 2022 in this retrospective, single-center study. All patients underwent a [ We included 131 NET patients with a total of 34 [ We confirmed a higher and very frequent UP uptake in latest SiPM-detector [

Identifiants

pubmed: 38910232
doi: 10.1186/s41824-024-00203-x
pii: 10.1186/s41824-024-00203-x
doi:

Types de publication

Journal Article

Langues

eng

Pagination

18

Informations de copyright

© 2024. The Author(s).

Références

Al-Ibraheem A, Bundschuh RA, Notni J, Buck A, Winter A, Wester HJ, Schwaiger M, Scheidhauer K (2011) Focal uptake of 68 Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours? Eur J Nucl Med Mol Imaging 38:2005–2013
doi: 10.1007/s00259-011-1875-0 pubmed: 21792572
Ashrafinia S, Mohy-ud-Din H, Karakatsanis NA, Jha AK, Casey ME, Kadrmas DJ, Rahmim A (2017) Generalized PSF modeling for optimized quantitation in PET imaging. Phys Med Biol 62(12):5149
doi: 10.1088/1361-6560/aa6911 pubmed: 28338471
Bauckneht M, Albano D, Annunziata S, Santo G, Guglielmo P, Frantellizzi V, Branca A, Ferrari C, Vento A, Mirabile A, Nappi AG, Laudicella R (2020) Somatostatin receptor PET/CT imaging for the detection and staging of pancreatic NET: a systematic review and meta-analysis. Diagnostics 10(8):598
doi: 10.3390/diagnostics10080598 pubmed: 32824388 pmcid: 7459584
Boughdad S, Meyer M, Prior JO, Fernandes V, Allenbach G, Kamani C, Jreige M, Albano D, Bertagna F, Nicod-Lalonde M, Schaefer N, Treglia G (2021) Prevalence of physiological uptake in the pancreas on somatostatin receptor-based PET/CT: a systematic review and a meta-analysis. Clin Transl Imaging 9(4):353–360
doi: 10.1007/s40336-021-00432-1
Brabander T, Teunissen J, Kwekkeboom D (2017) Physiological uptake in the pancreatic head on somatostatin receptor scintigraphy using [111In-DTPA] octreotide: incidence and mechanism. Clin Nucl Med 42(1):15–19
doi: 10.1097/RLU.0000000000001431 pubmed: 27775943
Calabrò D, Argalia G, Ambrosini V (2020) Role of PET/CT and therapy management of pancreatic neuroendocrine tumors. Diagnostics 10(12):1059
doi: 10.3390/diagnostics10121059 pubmed: 33297381 pmcid: 7762240
Chen SH, Chang YC, Hwang TL, Chen JS, Chou WC, Hsieh CH, Yeh TS, Hsu JT, Yeh CN, Tseng JH, Chen TC, Yen TC (2018) 68Ga-DOTATOC and 18F-FDG PET/CT for identifying the primary lesions of suspected and metastatic neuroendocrine tumors: a prospective study in Taiwan. J Formosan Med Assoc 117(6):480–487
doi: 10.1016/j.jfma.2017.07.007 pubmed: 28735662
Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O’connor JM, Salazar R, Taal BG, Vullierme MP, O’toole D (2012) ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology 95(2):120–134
doi: 10.1159/000335587 pubmed: 22261872
Ferretti A, Chondrogiannis S, Rampin L, Bellan E, Marzola MC, Grassetto G, Gusella S, Maffione AM, Gava M, Rubello D (2018) How to harmonize SUVs obtained by hybrid PET/CT scanners with and without point spread function correction. Phys Med Biol 63(23):235010
doi: 10.1088/1361-6560/aaee27 pubmed: 30474620
Jacobsson H, Larsson P, Jonsson C, Jussing E, Grybäck P (2012) Normal uptake of 68Ga-DOTA-TOC by the pancreas uncinate process mimicking malignancy at somatostatin receptor PET. Clin Nucl Med 37(4):362–365
doi: 10.1097/RLU.0b013e3182485110 pubmed: 22391705
Johnbeck CB, Knigge U, Kjær A (2014) PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature. Future Oncol 10(14):2259–2277
doi: 10.2217/fon.14.139 pubmed: 25471038
Kabasakal L, Demirci E, Ocak M, Decristoforo C, Araman A, Ozsoy Y, Uslu I, Kanmaz B (2012) Comparison of 68 Ga-DOTATATE and 68 Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 39:1271–1277
doi: 10.1007/s00259-012-2123-y pubmed: 22526963
Kunikowska J, Królicki L, Pawlak D, Zerizer I, Mikolajczak R (2012) Semiquantitative analysis and characterization of physiological biodistribution of 68Ga-DOTA-TATE PET/CT. Clin Nucl Med 37(11):1052–1057
doi: 10.1097/RLU.0b013e31825b2555 pubmed: 22996234
Mapelli P, Tam HH, Sharma R, Aboagye EO, Al-Nahhas A (2014) Frequency and significance of physiological versus pathological uptake of 68Ga-DOTATATE in the pancreas: validation with morphological imaging. Nucl Med Commun 35(6):613–619
doi: 10.1097/MNM.0000000000000106 pubmed: 24686250
Nakamoto Y, Ishimori T, Sano K, Temma T, Ueda M, Saji H, Togashi K (2016) Clinical efficacy of dual-phase scanning using 68Ga-DOTATOC-PET/CT in the detection of neuroendocrine tumours. Clin Radiol 71(10):1069-e1
doi: 10.1016/j.crad.2016.04.017
Novruzov F, Aliyev A, Wan MYS, Syed R, Mehdi E, Aliyeva I, Giammarile F, Bomanji JB, Kayani I (2021) The value of [68Ga] Ga-DOTA-TATE PET/CT in diagnosis and management of suspected pituitary tumors. Eur J Hybrid Imaging 5(1):1–13
doi: 10.1186/s41824-021-00104-3
Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, Brandau W, Bockisch A, Boy C (2011) 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors. J Nucl Med 52(12):1864–1870
doi: 10.2967/jnumed.111.091165 pubmed: 22072704
Portela-Gomes GM, Stridsberg M, Grimelius L, Öberg K, Janson ET (2000) Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas. Appl Immunohistochem Mol Morphol 8(2):126–132
doi: 10.1097/00129039-200006000-00007 pubmed: 10937060
Wittingen J, Frey CF (1974) Islet concentration in the head, body, tail and uncinate process of the pancreas. Ann Surg 179(4):412
doi: 10.1097/00000658-197404000-00005 pubmed: 4593099 pmcid: 1355988

Auteurs

Maria Firsova (M)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Rue du Bugnon 46, 1011, Lausanne, Switzerland.

Giorgio Treglia (G)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Rue du Bugnon 46, 1011, Lausanne, Switzerland.
Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Clinic of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Via A. Gallino 12, 6500, Bellinzona, Switzerland.
Academic Education, Research and Innovation Area, General Directorate, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.

Christine Sempoux (C)

Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Department of Pathology, Lausanne University Hospital, Lausanne, Switzerland.

Clarisse Dromain (C)

Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Department of Radiology, Lausanne University Hospital, Lausanne, Switzerland.

John O Prior (JO)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Rue du Bugnon 46, 1011, Lausanne, Switzerland.
Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Niklaus Schaefer (N)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Rue du Bugnon 46, 1011, Lausanne, Switzerland.
Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Sarah Boughdad (S)

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Rue du Bugnon 46, 1011, Lausanne, Switzerland. sarah.boughdad@chuv.ch.

Classifications MeSH